April 17, 2014 9:22 AM ET

Biotechnology

Company Overview of InNexus Biotechnology, Inc.

Executive Profile

Ronald Levy M.D., Ph.D.

Member of Scientific Advisory Board, Five Prime Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 11 different industries.

See Board Relationships
----

Background

Dr. Ronald Levy, also known as Ron, MD, PhD serves as the Chief of the Division of Oncology at Stanford University. Dr. Levy serves as a Professor of Medicine and Chief, Division of Oncology and Director of the Lymphoma Program at Stanford University School of Medicine. Dr. Levy serves as a Member of Scientific Advisory Board of Five Prime Therapeutics Inc. He serves as a Director of American Association For Cancer Research. He serves as a Member of Scientific Advisory ...

Corporate Headquarters

145 South 79th Street
Chandler, Arizona 85226

United States

Phone: 480-862-7500
Fax: 480-657-8919

Board Members Memberships

Director

Education

BA 1963
Harvard University
MD 1968
The Board of Trustees of The Leland Stanford Junior University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact InNexus Biotechnology, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.